Showing results (241-250 of 498) with videos related to
Sort By:
Pageof 50
Blood|March 9, 1999
Cytokine-based tumor cell vaccine is equally effective against parental and isogenic multidrug-resistant myeloma cells: the role of cytotoxic T lymphocytesA A Shtil, J G Turner, J Durfee, et al.Journal of the National Cancer Institute. Monographs|January 1, 1993
In vitro evaluation of chemosensitizers for clinical reversal of P-glycoprotein-associated Taxol resistanceM Lehnert, S Emerson, W S Dalton, et al.Clinical Pharmacology and Therapeutics|September 1, 1975
Effects of marihuana combined with secobarbitalW S Dalton, R Martz, L Lemberger, et al.International Journal of Cancer|May 16, 1996
Resistance to the chemosensitizer verapamil in a multi-drug-resistant (MDR) human multiple myeloma cell lineM R Abbaszadegan, N E Foley, M C Gleason-Guzman, et al.Clinical Pharmacology and Therapeutics|December 1, 1976
Influence of cannabidiol on secobarbital effects and plasma kineticsW S Dalton, R Martz, B E Rodda, et al.Journal of the National Cancer Institute|May 3, 1989
Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by P-glycoprotein stainingS E Salmon, T M Grogan, T Miller, et al.Biotechniques|October 1, 1996
Semi-automated PCR method for quantitating MDR1 expressionS Zhao, U Consoli, R Arceci, et al.Cancer Research|July 23, 2003
BRAF oncogenic mutations correlate with progression rather than initiation of human melanomaJianli Dong, Robert G Phelps, Rui Qiao, et al.BMC Genomics|April 18, 2015
Rapid identification and recovery of ENU-induced mutations with next-generation sequencing and Paired-End Low-Error analysisLuyuan Pan, Arish N Shah, Ian G Phelps, et al.The American Journal of Dermatopathology|June 20, 2015
Histopathology of Measles: Report of 2 Cases With New FindingsHarleen K Sidhu, Julien Lanoue, Rachel Nazarian, et al.Pageof 50